ReviewClinical neuroradiology2026
Identifying Intracranial Atherosclerotic Disease in Emergent Large Vessel Occlusion.
Review in Clinical neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracranial atherosclerotic disease (ICAD) represents a substantial proportion of large vessel occlusion (LVO) strokes refractory to mechanical thrombectomy, yet its diagnosis in the hyperacute setting remains challenging without direct vessel-wall imaging.
methodsThis narrative review is intended as a narrative and conceptual roadmap, acknowledging the inherent limitations of current methodologies for assessing ICAD in LVO patients. We evaluate clinical, pre-procedural imaging, angiographic, and intraprocedural features supporting a diagnosis of ICAD-related LVO, drawing on own experience and evidence from the literature. Articles were selected by authors for relevance to the conceptual framework. Randomized controlled trials, systematic reviews, and mechanistic pre-clinical studies were prioritized where available.
resultsTruncal occlusion morphology, fixed residual stenosis after thrombectomy, and early reocclusion emerge as the most reproducible high-specificity markers, while clinical risk-factor profile, absence of the susceptibility vessel sign, and collateral or perfusion patterns provide corroborating rather than standalone evidence. DISCUSSION: We propose a tiered diagnostic framework combining these markers to guide real-time decisions on bailout angioplasty or stenting, alongside a differential diagnosis of non-atherosclerotic mimics. Existing prediction scores show promising discriminative performance but remain largely unvalidated outside their Asian derivation cohorts. We propose illustrative enrollment criteria for future randomized trials, informed by recent studies.
conclusionSystematic, reproducible recognition of ICAD is essential to guide bailout treatment decisions and to enable rigorous evaluation of endovascular strategies tailored to this distinct stroke subtype.
Indexed as
Identifiers
42850452What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.